RxNorm Names
LORATADINE solution
[Major Pharmaceuticals, Inc]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72500b55-efa6-4b7c-9946-cee6bfc05970| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | Abbreviated New Drug Application |
Uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- itchy, watery eyes
- sneezing
- itching of the nose or throat
Warnings
Do not use if you have ever had allergic reaction to this product or any of it's ingredients
Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product do not take more than directed. Taking more than directed may cause drowsiness.
Directions
| adults and children 6 years and over | 2 teaspoonfuls (TSP) daily; do not take more than 2 teaspoonfuls (TSP) in 24 hours |
| children 2 to under 6 years of age | 1 teaspoonful (TSP) daily; do not take more than 1 teaspoonful (TSP) in 24 hours |
| children under 2 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
Other information
- Each teaspoonful contains: sodium 1 mg
- Safety Sealed. Do not use if imprinted seal around cap is broken or missing
- Store between 20° to 25°C (68° to 77°F)
Inactive ingredients
Butylated hydroxylanisole, citric acid, glycerin, grape flavor, propylene glycol, purified water, sodium benzoate, sucralose.
| LORATADINE
loratadine solution |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
| Labeler - Major Pharmaceuticals, Inc (191427277) |
Revised: 12/2012
Document Id: 6433c2bf-a196-496f-9e20-4f134a126261
Set id: 72500b55-efa6-4b7c-9946-cee6bfc05970
Version: 4
Effective Time: 20121227
Major Pharmaceuticals, Inc
Review RxNorm Normal Forms